1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Vulvar Squamous Cell Carcinoma: new trials by email Literature Review of Vulvar Squamous Cell Carcinoma trials Research Report on Vulvar Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma Patients Imiquimod 5% cream, Nivolumab - Vulvar Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Centre Leon Berard | 50 | 2026-09-01 | 2026-09-30 |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas EVOLVE104 - Bladder Cancer, Squamous Cell Carcinoma of the Lung | Phase 1 | Recruiting | EvolveImmune United, Inc | 160 | 2025-11-13 | 2026-09-15 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 20 | 2018-07-18 | 2023-09-13 |
Anus Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Urinary Bladder Neoplasms (1) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1) · Vulvar Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Anus Diseases (1) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Esophageal Neoplasms (1) · Gastrointestinal Diseases (1)
Disulfides (1) · Imiquimod (1) · Immunoglobulin G (1) · Nivolumab (1) · Radiosurgery (1) · durvalumab (1) · tremelimumab (1)
Centre Leon Berard (1) · EvolveImmune United, Inc (1) · M.D. Anderson Cancer Center (1)
United States (2) · France (1)
Lilie L Lin (1)